Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia

This study has been completed.
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Identifier:
First received: July 7, 2005
Last updated: June 6, 2011
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):